Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art - Campos - 2016 - Reviews in Medical Virology - Wiley Online Library
Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance - ScienceDirect
Letermovir | C29H28F4N4O4 - PubChem
Letermovir and maribavir for pan‐resistant cytomegalovirus infection in a patient with haematologic malignancy: Consideration for combination therapy - Dickter - - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Letermovir drug review
Antiviral Drug Resistance of Human Cytomegalovirus | Clinical Microbiology Reviews
PDF) Letermovir and inhibitors of the terminase complex: A promising new class of investigational antiviral drugs against human cytomegalovirus
Frontiers | Tuning the Orchestra: HCMV vs. Innate Immunity | Microbiology
Letermovir - LiverTox - NCBI Bookshelf
Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance - ScienceDirect
Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation | NEJM
How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients. - Abstract - Europe PMC
Diagnosis and Discussion -- Case 1074
The human cytomegalovirus terminase complex as an antiviral target: a close-up view. - Abstract - Europe PMC
Letermovir - Wikipedia
Pharmacology of letermovir and maribavir. | Download Scientific Diagram
Letermovir: First Global Approval | SpringerLink
PDF] New therapies for human cytomegalovirus infections. | Semantic Scholar
Letermovir - Wikipedia
Frontiers | Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules | Microbiology
New therapies for human cytomegalovirus infections - ScienceDirect
How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients - ScienceDirect
PDF] Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus | Semantic Scholar
Maribavir, brincidofovir and letermovir: Efficacy and safety of new antiviral drugs for treating cytomegalovirus infections - ScienceDirect
Letermovir for prophylaxis of cytomegalovirus manifestations in adult allogeneic hematopoietic stem cell transplant recipients | Future Microbiology